BRIEF published on 05/12/2026 at 07:50, 5 months 30 days ago Eckert & Ziegler Announces Positive Start to 2026 Sales Growth EBIT Decline Net Income Increase Medical Segment 2026 Forecast
BRIEF published on 05/12/2026 at 07:50, 5 months 30 days ago Eckert & Ziegler annonce un début d'année 2026 positif Croissance Des Ventes Augmentation Du Revenu Net Secteur Médical Prévisions Pour 2026 Baisse Du Résultat D'exploitation
PRESS RELEASE published on 05/12/2026 at 07:45, 5 months 30 days ago Eckert & Ziegler with a Successful Start to the Year. 2026 Forecast Confirmed. Eckert & Ziegler SE reports successful start to 2026 with increased sales and confirmed 2026 forecast. Sales up by 7% in Q1 2026 Sales Financial Performance Quarterly Results Eckert & Ziegler SE 2026 Forecast
BRIEF published on 04/20/2026 at 09:05, 6 months 20 days ago NuWays AG Recommends Buying Eckert & Ziegler SE Stocks Buy Recommendation Eckert & Ziegler SE Quarterly Earnings Radiopharma Medical Segment Growth
BRIEF published on 04/20/2026 at 09:05, 6 months 20 days ago NuWays AG recommande l'achat d'actions Eckert & Ziegler SE Recommandation D'achat Résultats Trimestriels Eckert & Ziegler SE Radiopharma Croissance Du Segment Médical
PRESS RELEASE published on 04/20/2026 at 09:00, 6 months 20 days ago Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY Eckert & Ziegler SE receives updated research recommendation from NuWays AG projecting continued growth in the Medical segment, with Q1 results expecting sales growth of 6% yoy NuWays AG Research Q1 Results Eckert & Ziegler SE Medical Segment
BRIEF published on 04/14/2026 at 10:02, 6 months 26 days ago Eckert & Ziegler Gains Attention with Buy Rating and Strong Upside Potential Eckert & Ziegler BUY Rating Price Target Nuclear Medicine Upside Potential
BRIEF published on 04/14/2026 at 10:02, 6 months 26 days ago Eckert & Ziegler attire l'attention avec une recommandation d'achat et un fort potentiel de hausse Objectif De Prix Potentiel De Hausse Médecine Nucléaire Évaluation D'achat Eckert Et Ziegler
PRESS RELEASE published on 04/14/2026 at 09:57, 6 months 26 days ago Eckert & Ziegler: Metzler Initiates Coverage with a Buy Rating and a Price Target of € 21.00. Upside Potential: 41% Metzler initiates coverage on Eckert & Ziegler SE with a Buy rating and a price target of €21.00, citing strong market position in nuclear medicine BUY Rating Price Target Eckert & Ziegler SE Nuclear Medicine Metzler
BRIEF published on 04/10/2026 at 10:05, 7 months ago Eckert & Ziegler obtient la certification MDR pour le traitement du cancer de l'œil critique Certification MDR Règlement Sur Les Dispositifs Médicaux Traitement Du Cancer De L'œil Brachythérapie Applicateurs Oculaires Ru-106
Published on 11/11/2026 at 03:30, 4 hours 22 minutes ago CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary
Published on 11/11/2026 at 00:40, 7 hours 12 minutes ago Upgraded Tunkillia MRE Validates Optimised Scoping Study
Published on 11/10/2026 at 23:30, 8 hours 22 minutes ago CCL Industries Announces 2026 Third Quarter Results
Published on 11/10/2026 at 23:00, 8 hours 52 minutes ago Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/10/2026 at 23:00, 8 hours 52 minutes ago Battery X Metals Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/11/2026 at 07:30, 22 minutes ago GESCO reports significant increase in earnings in the first nine months and shows stable business performance in a challenging market environment
Published on 11/11/2026 at 07:30, 22 minutes ago voestalpine: voestalpine with solid results in the first half of 2026/27
Published on 11/11/2026 at 07:30, 22 minutes ago SFC Energy AG publishes nine-month report – record quarter in Q3, strong profitable growth and favourable product mix result in disproportionately strong earnings performance
Published on 11/11/2026 at 07:30, 22 minutes ago hGears Group delivers results in line with expectations in the first nine months of 2026
Published on 11/11/2026 at 07:30, 22 minutes ago VINCORION significantly increases revenue in the first nine months of 2026 and confirms raised full-year guidance
Published on 11/10/2026 at 18:00, 13 hours 52 minutes ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 14 hours 7 minutes ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 14 hours 17 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 14 hours 20 minutes ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
